Brii Biosciences Limited (2137.HK)
HKD 0.85
(0.0%)
HKD 0.85
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 617 Thousand | 51.62 Million | 92.54 Million | 82.21 Million | 20.19 Million |
| Cost of Revenue | -55.27 Million | - | - | - | - |
| Gross Profit | 55.89 Million | 51.62 Million | 92.54 Million | 82.21 Million | 20.19 Million |
| Operating Expenses | 617 Thousand | 565.81 Million | 642.61 Million | 911.88 Million | 126.92 Million |
| Selling, General and Administrative Expenses | 57.1 Million | 80.32 Million | 79.3 Million | 49.83 Million | 22.54 Million |
| Research and Development Expenses | 402.7 Million | 440.63 Million | 494.61 Million | 875.79 Million | 83.78 Million |
| Other Expenses | - | 44.85 Million | 68.69 Million | -13.74 Million | 20.59 Million |
| Cost and Expenses | 545.34 Million | 565.81 Million | 642.61 Million | 911.88 Million | 126.92 Million |
| Operating Income | -544.3 Million | -520.61 Million | -4.23 Billion | -1.26 Billion | -525.21 Million |
| Interest Expense | 494 Thousand | 851 Thousand | 1.17 Million | 1.66 Million | 1.11 Million |
| Income Tax Expense | - | -37.15 Million | -70.85 Million | -77.22 Million | -4.18 Million |
| Earnings before Tax | -184.37 Million | -489.78 Million | -4.19 Billion | -1.28 Billion | -521.02 Million |
| Net Income | -174.82 Million | -452.62 Million | -4.12 Billion | -1.2 Billion | -516.84 Million |
| Earnings Per Share Basic | -0.24 | -0.63 | -9.38 | -1.71 | -0.73 |
| Earnings Per Share Diluted | -0.24 | -0.63 | -9.38 | -1.71 | -0.73 |
| Weighted Average Shares Outstanding | 728.1 Million | 723.47 Million | 439.04 Million | 706.2 Million | 706.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 728.1 Million | 723.47 Million | 439.04 Million | 706.2 Million | 706.2 Million |
| Gross Margin | 90.59 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -272.61 | -9.75 | -45.57 | -15.24 | -25.63 |
| Profit Margin | -283.35 | -8.77 | -44.52 | -14.67 | -25.59 |
| EBITDA | -168.2 Million | -503.58 Million | -602.79 Million | -890.78 Million | -124.11 Million |
| Earnings Before Tax Margin | -882.17 | -10.08 | -45.76 | -15.41 | -26.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 11.07 Million | 11.07 Million | 8.11 Million | 617 Thousand | 8.11 Million | 20.04 Million |
| Cost of Revenue | - | - | - | -55.27 Million | - | -19.35 Million |
| Gross Profit | 11.07 Million | 11.07 Million | 8.11 Million | 55.89 Million | 8.11 Million | 39.39 Million |
| Operating Expenses | 118.87 Million | 118.87 Million | 147.12 Million | 545.34 Million | 32.58 Million | 141.52 Million |
| Selling, General and Administrative Expenses | 55.79 Million | 55.79 Million | 46.85 Million | - | 46.85 Million | 52.1 Million |
| Research and Development Expenses | 63.08 Million | 63.08 Million | 100.26 Million | - | 100.26 Million | 101.08 Million |
| Other Expenses | - | - | - | 431 Thousand | - | - |
| Cost and Expenses | 118.87 Million | 118.87 Million | 147.12 Million | 545.34 Million | 32.58 Million | 141.52 Million |
| Operating Income | -107.79 Million | -107.79 Million | -139.01 Million | -544.73 Million | -139.01 Million | -133.14 Million |
| Interest Expense | - | - | - | 494 Thousand | - | 287.26 Thousand |
| Income Tax Expense | -1.35 Million | -1.35 Million | -1.31 Million | -9.54 Million | -1.31 Million | -7.81 Million |
| Earnings before Tax | -141.61 Million | -141.61 Million | 6.22 Million | -184.37 Million | 6.22 Million | -98.41 Million |
| Net Income | -140.26 Million | -140.26 Million | 7.54 Million | -174.82 Million | 7.54 Million | -94.95 Million |
| Earnings Per Share Basic | -0.19 | -0.19 | 0.01 | - | 0.01 | -0.13 |
| Earnings Per Share Diluted | -0.19 | -0.19 | 0.01 | - | 0.01 | -0.13 |
| Weighted Average Shares Outstanding | 729.71 Million | 729.71 Million | 728.74 Million | 728.1 Million | 728.74 Million | 727.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 729.71 Million | 729.71 Million | 728.71 Million | 728.1 Million | 728.71 Million | 727.48 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 90.59 | 1.00 | 1.97 |
| EBIT Margin | -9.63 | -9.63 | -16.96 | - | -16.96 | -6.54 |
| Profit Margin | -12.66 | -12.66 | 0.93 | -283.35 | 0.93 | -4.74 |
| EBITDA | -106.64 Million | -106.64 Million | -137.6 Million | - | -137.6 Million | -131.05 Million |
| Earnings Before Tax Margin | -9.73 | -9.73 | -17.14 | -882.87 | -17.14 | -6.64 |
1504
NIRO
HLMS
PRMG
STS
0010